Route To Better IVD Commercial Opportunities Outlined In UK Roadmap
Can diagnostics industry stakeholders take advantage of a rare opportunity?
The COVID-19 pandemic put disease diagnosis in the spotlight for the public and national health care systems alike. A UK report highlights how the IVD industry must capitalize on this unique moment in time.
You may also be interested in...
While the UK continues to develop the future medtech regulatory system for Great Britain, a new market access report recommends how the MHRA should simplify regulatory processes for SMEs.
A multi-stakeholder research and funding program led by deeptech innovation organization CPI has produced two UK medtech industry outlook reports and overseen a £7m innovation funding scheme. Training to help SMEs navigate their way through the medtech regulatory maze is another part the program, the findings of which were released to the public this month.
Inaugural artificial intelligence recommendations from NICE on radiotherapy contouring should allow clinicians to spend more time with patients and on complex cases where AI is not an option. But large language models are not appropriate in all cases, cautions Adrian Sutherland, principal healthcare architect at Endava consultancy.